LIVN Key Statistics, Chart & Performance
The current stock price of LIVN is 62.11 USD. In the past month the price decreased by -1.54%. In the past year, price increased by 28.59%.
LIVN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to LIVN. When comparing the yearly performance of all stocks, LIVN is one of the better performing stocks in the market, outperforming 82.75% of all stocks.
LIVN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to LIVN. LIVN has only an average score on both its financial health and profitability.
LIVN Financial Highlights
Over the last trailing twelve months LIVN reported a non-GAAP Earnings per Share(EPS) of 3.85. The EPS increased by 12.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.48% | ||
| ROE | -18.76% | ||
| Debt/Equity | 0.3 |
LIVN Forecast & Estimates
17 analysts have analysed LIVN and the average price target is 73.01 USD. This implies a price increase of 17.54% is expected in the next year compared to the current price of 62.11.
For the next year, analysts expect an EPS growth of 16.72% and a revenue growth 10.7% for LIVN
LIVN Ownership
LIVN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.4 | 211.72B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.14 | 189.66B | ||
| SYK | STRYKER CORP | 27.62 | 139.12B | ||
| BSX | BOSTON SCIENTIFIC CORP | 29.85 | 130.56B | ||
| BDX | BECTON DICKINSON AND CO | 14.36 | 59.11B | ||
| IDXX | IDEXX LABORATORIES INC | 56.73 | 57.12B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.82 | 48.95B | ||
| RMD | RESMED INC | 26.02 | 37.60B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.81 | 37.24B | ||
| DXCM | DEXCOM INC | 37.39 | 27.12B | ||
| PODD | INSULET CORP | 62.95 | 20.24B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.79 | 17.30B |
Related stock screener links
About LIVN
Company Profile
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. The firm designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Company Info
LIVANOVA PLC
20 Eastbourne Terrace
London W2 6LG GB
CEO: Damien McDonald
Employees: 2900
Phone: 442033250662
LIVANOVA PLC / LIVN FAQ
Can you describe the business of LIVANOVA PLC?
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. The firm designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Can you provide the latest stock price for LIVANOVA PLC?
The current stock price of LIVN is 62.11 USD. The price decreased by -1.71% in the last trading session.
Does LIVN stock pay dividends?
LIVN does not pay a dividend.
What is the ChartMill technical and fundamental rating of LIVN stock?
LIVN has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the Price/Earnings (PE) ratio of LIVANOVA PLC (LIVN)?
The PE ratio for LIVANOVA PLC (LIVN) is 16.13. This is based on the reported non-GAAP earnings per share of 3.85 and the current share price of 62.11 USD.
Should I buy LIVN stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LIVN.
How many employees does LIVANOVA PLC have?
LIVANOVA PLC (LIVN) currently has 2900 employees.